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renchyma-sparing resection which is guided by the PET-CT 
is always indicated in order to cure the patient. In diffuse CHI, 
however, the results of surgical therapy are unpredictable 
and cure is an exception. Therefore, a strong tendency exists 
nowadays that medical therapy should be preferred in dif-
fuse CHI. In atypical CHI the situation is more complex: if the 
focal lesion or the segmental mosaic are not too extensive, 
cure by resection should be possible. But care must be taken 
in atypical cases not to resect too much of the gland in order 
not to induce diabetes.  Copyright © 2011 S. Karger AG, Basel 
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 Abstract 
 For surgery in congenital hyperinsulinism (CHI), a distinct 
surgical strategy and technique is required for focal, diffuse 
and atypical CHI. In focal CHI, a confined, localized and pa-
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 Established Facts 
 • Focal congenital hyperinsulinism is always an indication for meticulous surgery irrespective of the lo-
calisation of the focus. If necessary, a Roux-en-Y jejunal loop is established to drain the pancreatic duct. 
A preoperative PET-CT in high quality is mandatory to distinguish between diff use and focal CHI and 
in the latter case to localize the focus. Resection of the focus is performed lobule for lobule directed by 
multiple frozen sections which must be examined by an experienced pathologist. Because success is 
highly dependent on the close collaboration of many highly specialized disciplines CHI should be tre-
ated only in experienced centers. 
 Novel Insights 
 • Diff use CHI nowadays is a domain of conservative therapy. Surgery is only indicated if medical treat-
ment fails to prevent severe hypoglycemia because the results of surgery in diff use CHI are unpre-
dictable. Th e role of surgery in atypical forms of CHI, however, like segmental mosaic and extensive 
focal forms which have been described just recently, needs to be evaluated. 
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 General Remarks 
 The surgical technique in congenital hyperinsulinism 
(CHI) is different from any other kind of pancreatic sur-
gery, especially from carcinoma surgery in adulthood. In 
focal CHI, the lesion is not a tumor per se like a carci-
noma or insulinoma, but rather an accumulation of dis-
eased islet cells secreting insulin without control. The 
lobular pancreatic structure is preserved  [1] . This is the 
reason why the focal lesion in most cases is neither dis-
tinguishable macroscopically by the eye, even when using 
magnifying lenses, nor by palpation.
 Radical surgery is mandatory in focal CHI because 
only a small amount of altered islet cells left in situ is 
enough to keep the infant hypoglycemic and to prevent 
cure  [2] . But in diffuse CHI, there has been a paradigm 
shift: mutilating surgery is no longer required and espe-
cially the near-total pancreatectomies which were advo-
cated in recent years are very seldom necessary nowa-
days. Conservative therapy has improved with long-term 
treatment using diazoxide, glucagon and octreotide  [3] . 
There is a high rate of spontaneous improvement of hy-
perinsulinemic hypoglycemia, probably by apoptosis. On 
the contrary, the rate of diabetes mellitus after extended 
pancreatectomy is very high  [4] . 
 During surgery for CHI the vital structures must be 
respected: the pancreatic duct, the choledochal duct, du-
odenum, superior mesenteric artery and vein, the venous 
confluens and the portal vein.
 As the focal lesion never grows by infiltration it is
normally easy to get away from vessels and bowel. There 
are two technical challenges, however: in infancy, the 
pancreatic duct is very thin and vulnerable. It is difficult 
to identify the duct before it is injured and lacerated. 
There is no way to suture or reconstruct the pancreatic 
duct because of the small diameter, the thin wall and the 
digestive power and aggressiveness of the pancreatic juic-
es. Therefore, a Roux-en-Y loop is necessary for drainage. 
Normally this heals nicely without long-term sequelae 
but sometimes a disturbance of the intestinal passage 
with chronic abdominal pain ensues or even adhesion
ileus.
 The second challenge is the choledochal duct. It is eas-
ier to recognize because its wall is thicker and it is not as 
fragile. But if the surgical dissection comes too close there 
is the risk of ischemia and resulting stricture. If it is severe 
a hepaticojejunostomy with a Roux-en-Y loop must be 
created which carries the risk of adhesions and cholangi-
tis.
 Surgical Strategy in the Various Forms of CHI 
 In CHI we differentiate the typical forms – focal and 
diffuse – and the atypical forms – segmental mosaic and 
extensive focal. Whereas the focal form shows a single 
circumscribed lesion with normal or suppressed islets in 
the rest of the gland, the diffuse form is characterized 
by abnormal giant   -cell nuclei throughout the pan-
creas.
 The surgical strategy in focal CHI is to remove all dis-
eased islet cells with as less collateral damage as possible. 
In diffuse CHI the aim is to reduce the number of dis-
eased cells in order to make medical treatment more ef-
fective  [5] . Even today the optimal extension of the resec-
tion to achieve this aim it is not known. Specifications 
vary between 50, 75, and 95% (subtotal) or 98% (near-
total). The differentiation between 95 and 98% is very dif-
ficult in an organ which in infancy is as big as the index 
finger of the surgeon.
 Atypical forms of CHI have been described and dis-
tinguished by Yves Aigrain [pers. commun.]; they in-
clude segmental mosaic and extensive focal forms. 
Whereas segmental mosaic forms are characterized by 
the accumulation of conspicuous and resting islets in a 
segmental distribution, the extensive focal form shows 
one large focal lesion often occupying huge parts of the 
pancreas with normal or suppressed islets in the remain-
ing gland. Surgical strategy in the extensive focal CHI 
consists in removing the whole focus and in the mosaic 
form the aim is to identify and remove all focal lesions 
without exception. As much healthy tissue as possible 
should be preserved in any case.
 Impact of New Diagnostic Tools:
[ 18 F]fluoro- L -DOPA PET-CT 
 In recent years, there has been a paradigm shift con-
cerning the diagnostic tools as well. Invasive radiological 
procedures like pancreatic venous sampling or pancre-
atic arterial calcium stimulation test have been aban-
doned in most centers because of their low sensitivity and 
specificity, the huge radiation load and blood loss. The 
integrated [ 18 F]fluoro- L -DOPA PET-CT, therefore, has 
been a giant step further. In specialized centers the spec-
ificity of the PET to distinguish between diffuse and focal 
CHI has been shown to be nearly 100%  [6] . The sensitiv-
ity of [ 18 F]fluoro- L -DOPA PET has been reported to be 
between 88 and 94%  [7] , but is even higher with modern 
integrated PET-CT techniques. The focal lesion can be 
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localized within the gland with an accuracy of millime-
ters. Anatomical landmarks are the tip of the pancreatic 
tail and the venous confluens.
 Surgical Technique in  Focal CHI 
 Open Approach 
 The child is lying supine, with a pillow under the back. 
The lordosis of the spine should be exactly the same as 
during the PET-CT in order to ensure a comparable posi-
tion. A gastric tube is inserted to deflate the stomach and 
the colon should have been emptied the day before.
 After a transverse incision of the upper abdomen, the 
omental bursa is opened by dividing the gastrocolic liga-
ment and the pancreas is exposed. It is scrutinized from 
the uncinate processus to the tail. In the majority of cases, 
no abnormality will be found even by magnifying glasses. 
As a first step, three superficial small biopsies are taken 
from the head, corpus and tail, from areas which were 
inconspicuous in the PET-CT ( fig. 1 ). Hemostasis at the 
biopsy site is ensured by fine ligature. Electrical coagula-
tion carries the risk of a pancreatic fistula and has to be 
avoided whenever possible.
 Frozen section examination of the biopsy specimen is 
done by an experienced pathologist who ideally is next to 
the operation theater. If the biopsy shows normal or sup-
pressed islets, diffuse CHI can be ruled out. If there is a 
suspicion of diffuse disease by histopathology, the opera-
tion is aborted because nowadays this is no indication for 
primary surgery. Modern imaging, however, has a close 
correlation with histopathology  [6] .
 In focal CHI, the dissection now concentrates on the 
area where the PET-CT has localized the focus. The tissue 
is dissected lobule for lobule under permanent frozen 
section control ( fig. 2 ). It can be a matter of tenths of a 
millimeter to find or miss the focal lesion. Frozen section 
numbers of 20 or more and operation times of 4 h and 
more are normal. In a recent approach, intraoperative ul-
trasonography has been used for a more precise localiza-
tion of foci which were preoperatively located using inte-
grated [ 18 F]fluoro- L -DOPA PET-CT. This method should 
allow to confirm the position of the focus in relation to 
the pancreatic duct and the blood vessels, in order to re-
duce the extent of resection  [8] . Once the focal lesion has 
been found, in many cases deep inside the pancreatic pa-
renchyma, the extent can be estimated now by the ap-
pearance of the suspicious tissue which is slightly more 
reddish in comparison to the surrounding pale yellow 
normal gland tissue. Normally the diameter of the focal 
lesion is 7–12 mm. Often, octopus-like tentacles can be 
observed which extend with fine branches into the sur-
rounding healthy parenchyma. All these must be resect-
ed  [2] .
 The technique of the dissection is to some extent 
sharply by a knife or scissors, in part bluntly by a hemo-
 Fig. 1. Biopsies from the healthy pancreas 
to prove focal and to exclude diffuse dis-
ease. 
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stat or forceps. The main pancreatic duct is vulnerable, 
but more stable than the soft surrounding pancreatic pa-
renchyma. By this tearing technique the duct can be iden-
tified in many cases before violating it. If the focus local-
ization is in the dorsal parts of the pancreas, the pancre-
atic head must be mobilized by a Kocher maneuver and 
the approach continues from behind.
 Once the focus has been removed totally, sometimes a 
sharp rise in blood glucose can be observed. In our expe-
rience, however, this is not a reliable sign. Of utmost im-
portance are the frozen section biopsies from the remain-
ing pancreatic tissue in all five directions: up, down, left, 
right and in the depth to look for any remaining tentacles. 
Every single tentacle can be the reason for persisting hy-
poglycemia.
 Hemostasis is accomplished with caution. Pancreatic 
tissue is supplied by numerous small arteries. Most hem-
orrhages will stop by spontaneous arterial constriction 
and thrombosis under mild compression. If necessary, an 
absorbable ligature is applied. 
 Electrical coagulation is used with extreme caution 
because of the risk of a pancreatic fistula induced by ne-
crosis. Small branches of the pancreatic duct will close 
spontaneously, but if the main duct is opened there is no 
way to close it again. If the wall is too thin and the diges-
tive juice too aggressive, Roux-en-Y pancreatico-jejunal 
anastomosis is inevitable ( fig. 3 ). A small silicone drain-
age is left at the resection site. It is removed after a few 
days if it is dry. Otherwise it must be left in place to avoid 
pseudocyst formation, sometimes for weeks.
 Minimal Invasive Approach 
 There are case reports about focus enucleation by lap-
aroscopy if the focal lesion was identifiable by macro-
scopic view  [9] . The minimal invasive approach, how-
ever, is not recommended for lesions in the pancreatic 
head and corpus as many foci are located deep inside the 
parenchyma. However, if the PET-CT shows the lesion 
in the pancreatic tail, primary laparoscopic left resec-
tion is the treatment of choice. An excellent overview is 
mandatory: the stomach must be kept away by a liver 
hook or a temporary stitch to the abdominal wall. Biop-
sies can be taken as by the open approach and extreme 
care must be taken to dissect the pancreatic tail from the 
splenic vein. There are many small vessels between the 
pancreas and the splenic vein and they all must be di-
vided without bleeding or injury to the splenic vein 
which can result in thrombosis. The spleen must be pre-
served in any case during pancreatic tail resection be-
cause of the risk of overwhelming post-splenectomy in-
fection syndrome. When the resection appears to be ad-
equate, the parenchyma is divided transversely with the 
harmonic scalpel ( fig. 4 ). In infancy, this is a safe meth-
od for cutting and closing of the parenchyma, vessels 
 Fig. 2. Technique of atypical pancreatic resection lobule for lob-
ule. 
 Fig. 3. Drainage of the pancreatic duct by a Roux-en-Y pancreati-
co-jejunostomy. 
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and the pancreatic duct, and no stapler, suture or coagu-
lation is necessary.
 After tail resection, the pathologist confirms the local-
ization of the focus inside the specimen as well as clear 
resection margins by frozen section.
 Surgical Strategy in  Diffuse  CHI 
 Surgery in diffuse CHI nowadays is only indicated if 
medical therapy fails and the risk of neurological damage 
arises by uncontrollable hypoglycemia  [5] . The formerly 
advocated extensive subtotal or near-total resections, how-
ever, carry a substantial risk of diabetes at the age of pu-
berty at latest ( table 1 ). As until today the extension of pan-
creatic resection to prevent both persistent hypoglycemia 
and diabetes is not clear, we recommend to start with a left 
resection of about 50–75% of the pancreatic parenchyma. 
After careful dissection from the splenic vein the pancre-
atic gland is divided with the harmonic scalpel, e.g. above 
the mesenteric vessels. As there is no need for identifica-
tion or search for a focus, the laparoscopic approach is 
preferable for pancreatic resections in diffuse CHI. To keep 
the overview, tail and corpus can be removed in pieces.
 If there is no improvement in the medical options to 
prevent hypoglycemia after the first surgery, further re-
sections can be performed until only a small rim of pan-
creatic tissue around the choledochal duct remains. The 
risk of postoperative diabetes, however, increases with ev-
ery step as expected.
 Surgical Strategy in Segmental Mosaic and 
Extensive Focal CHI 
 The most challenging problem in atypical forms is to 
remove all diseased tissue without collateral damage  [1, 
5, 6] . Some foci are so extensive that they occupy great 
parts of the gland, and in the segmental mosaic form it is 
often difficult to find and identify all foci, because in the 
PET-CT, numerous, adjacent foci converge to one ‘hot 
spot’. In atypical cases, therefore, if diffuse CHI is ex-
cluded, and if huge parts of the gland have already been 
resected but still there are suspicious cells at the resection 
margins, it is wise to finish the operation, take the infant 
to the ward and wait a few weeks. In many cases, persis-
tent hypoglycemia will be controllable by medication and 
hence mutilating surgery is not indicated in atypical cas-
es as the first step.
 Results of Surgical Therapy for CHI 
 When looking at the results of surgical therapy in 
CHI, it must be recognized that they are difficult to com-
pare because in a few publications it is not distinguished 
clearly between diffuse and focal forms of CHI and the 
extent of pancreatic resection often is not specified in de-
tail.
 Taken together, these results suggest that in focal CHI 
a limited pancreatic resection results in complete cure in 
most cases. In the past, however, many resections were 
too extensive for focal disease. This may partly be due to 
the fact that the PET-CT for CHI became available only 
in 2004. On the contrary, in diffuse disease a definitive 
cure after surgery is a rare exception, no matter how ex-
tensive the resection has been. As a rule, either recurrent 
hypoglycemia or diabetes will ensue.
 Complications 
 Complications after pancreatic surgery for CHI in in-
fancy are rare  [2] . Most common is prolonged pancreatic 
secretion from small branches of the pancreatic duct at 
the resection site. If they are adequately drained, they 
cease spontaneously. However, this can take several 
weeks. Secretions can also arise from the pancreatic 
stump or from the suture line of a pancreatico-jejunosto-
my. If the pancreatic duct has been opened, a pseudocyst 
will probably ensue.
 Fig. 4. Pancreatic tail resection with the harmonic scalpel. No su-
ture, coagulation, or stapling device is necessary in the infantile 
pancreas. 
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 Bleeding can occur from small parenchymal vessels. 
Blood loss is minimal and it usually ceases spontaneous-
ly. However, septic arrosion bleeding in the setting of a 
septic complication is a serious event and vital threat be-
cause usually voluminous vessels like the splenic artery 
or vein are affected. 
 Infection is rare and in most cases is the result of a 
leakage of pancreatic or jejunal juice which is not suffi-
ciently drained.
 Persistence of hypoglycemia, exocrine pancreatic in-
sufficiency and diabetes mellitus should not occur nowa-
days if the surgical strategy as outlined above has been 
considered.
 Conclusion 
 Great advances have been made in the understanding, 
diagnosis and therapy of CHI in the past years. Modern 
imaging is able to differentiate between the diffuse and 
focal form and in the latter case to localize the focus with-
in the gland with high precision. Whereas surgery in dif-
fuse forms is only indicated when medical treatment 
fails, a complete cure can be achieved in the focal form by 
partial pancreatic resection. Because surgery for CHI dif-
fers fundamentally from the carcinoma surgery in adult-
hood, infants should be treated only in highly specialized 
pediatric surgical centers. 
Table 1.  Results of surgical therapy of CHI
Year First author n Type of CHI Extension of 
resection
Euglycemia Hypoglycemia (recurrence) Hyperglycemia and/
or diabetes
1997 Shilyansky [10] 27 not specified 95%, n = 20 n = 10 (37%) n = 2 (7%) 95%, n = 9 (69%) 
98%, n = 7 98%, n = 6 (86%)
1998 Rahier [11] 20 diffuse, n = 13 diffuse 80–98% diffuse, n = 2 (15%) diffuse, n = 8 (61%) diffuse, n = 3 (23%)
focal, n = 7 focal 5–60% focal, n = 7 (100%) focal, n = 0 focal, n = 0
1999 Lovvorn [12] 53 diffuse, n = 42 ;80–98% diffuse, n = 14 (33%) diffuse, n = 7 (17%) diffuse, n = 7 (17%)
focal, n = 11 focal, n = 9 (82%) focal, n = 1 (9%) focal, n = 0
1999 de Lonlay [13] 52 diffuse, n = 30 diffuse 98% n = 2 (7%) n = 13 (43%) n = 15 (50%)
focal, n = 22 focal partial n = 22 (100%) n = 0 n = 0
2003 Meissner [14] 63 diffuse + focal 80–≥95%
+ partial
27% 40% 27% after 1st surgery 
71% after reoperation
2003 Jack [15] 34 diffuse + focal ≥95% n = 13 (38%) n = 18 (53%) after 1st surgery n = 9 (26%)
2003 McAndrew [4] 48 diffuse + focal 95%, n = 42 n = 16 (33%) n = 12 (25%) after 1st surgery n = 20 (42%)
2004 Suchi [16] 52 diffuse, n = 18 diffuse 98% diffuse, n = 2 (11%) diffuse, n = 9 (50%) diffuse, n = 7 (39%)
focal, n = 30 
not specified, n = 4
focal 10–93% focal, n = 26 (87%) focal, n = 4 (13%) focal, n = 0
2004 Adzick [2] 35 focal partial n = 35 (92%) n = 3 (8%) 0
2005 Cherian [17] 10 not specified 95% 0 0 10 (100%)
2008 Barthlen [6] 10 focal, n = 9
atypical, n = 1
5–50% 9 (90%) 1 (10%) 0
2009 Al-Shanafey [18] 18 diffuse + focal 90–93% n = 6 (33%) n = 9 (50%) n = 3 (17%)
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